THRX

Theravance, Inc. News Headlines

$23.88
*  
1.44
5.69%
Get THRX Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
7/24/2014 3:47:00 AM - Zacks.com

Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
7/24/2014 3:47:00 AM - Zacks.com

Theravance/Glaxo Commence Global Late stage Study on COPD - Analyst Blog
7/16/2014 6:42:00 PM - Zacks.com

GlaxoSmithKline, Theravance Begin Phase 3 Trial For Triple Combination Treatment
7/16/2014 2:21:00 AM - RTT News

Stocks To Watch: Apple, BlackBerry, United Continental...
7/11/2014 7:30:00 AM - Seeking Alpha

GlaxoSmithKline Is Moving Forward After Woeful Performance
7/8/2014 5:27:00 PM - Seeking Alpha

Glaxo/Theravance Drug Gets Japanese Approval - Analyst Blog
7/7/2014 12:00:00 PM - Zacks.com

GlaxoSmithKline: Anoro Ellipta Gets Approval In Japan For Treatment Of COPD
7/7/2014 8:16:00 AM - RTT News

GSK And Theravance : Anoro Ellipta Gets Approval In Japan For Treatment Of COPD
7/4/2014 9:10:00 AM - RTT News

Glaxo/Theravance Seek to Expand Breo Ellipta's Label - Analyst Blog
7/1/2014 11:50:00 AM - Zacks.com

Why Theravance (THRX) Could Be Positioned for a Surge? - Tale of the Tape
7/1/2014 8:42:00 AM - Zacks.com

Glaxo, Theravance File Asthma Drug Application with FDA
6/30/2014 8:43:00 AM - Dow Jones Business News

GSK And Theravance Announce Submission Of SNDA To FDA For FF/VI In Asthma
6/30/2014 8:28:00 AM - RTT News

GSK, Theravance Report Positive Data From Two Studies Involving Incruse Ellipta
6/11/2014 8:08:00 AM - RTT News

GlaxoSmithKline Posts Positive Results for Pulmonary Disease Drug
6/11/2014 8:04:00 AM - Dow Jones Business News

Theravance To Present At Jefferies Conference; Webcast At 9:00 AM ET
6/4/2014 8:00:00 AM - RTT News

Seth Klarman's Baupost: Investment Changes During The First Quarter
5/19/2014 11:40:00 AM - Seeking Alpha

Tracking Seth Klarman's Baupost Group Holdings - Q1 2014 Update
5/15/2014 4:18:00 AM - Seeking Alpha

GlaxoSmithKline Gets European Marketing Authorization for Anoro
5/8/2014 11:50:00 AM - Dow Jones Business News

Split Update Overshadows Wider Q1 Loss at Theravance - Analyst Blog
5/7/2014 11:40:01 AM - Zacks.com

THERAVANCE Q1 14 Earnings Conference Call At 5:00 PM ET
5/6/2014 3:00:00 PM - RTT News

Glaxo, Theravance Launches Anoro Ellipta In U.S
4/28/2014 9:29:00 AM - RTT News

Update on Glaxo/Theravance's COPD Drugs - Analyst Blog
4/24/2014 6:33:01 PM - Zacks.com

Has Theravance Just Given Away 40% Of Its Value?
4/22/2014 8:43:00 AM - Seeking Alpha

Sector Update: Health Care
4/21/2014 8:22:04 AM - MT Newswires